Mitomics Inc.
Records under this name other than patents Mitomics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Mitomics Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,400,290 | Mitochondrial DNA deletion between about residues 12317-16254 for use in the detection of cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,008,008 | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,308,987 | 3.4 kb mitochondrial DNA deletion for use in the detection of cancer Formerly held Term ended Ended no later than Apr 18, 2026 · From the USPTO record | Term ended | Ended no later than Apr 18, 2026 | From the USPTO record |
| US 8,715,960 | Aberrant mitochondrial DNA, associated fusion transcripts and translation products and hybridization probes therefor Formerly held Lapsed on the fee record Ended May 6, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2022 | From the USPTO record |
| US 9,745,632 | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers Formerly held Lapsed on the fee record Ended Aug 29, 2021 · From the USPTO record | Lapsed on the fee record | Ended Aug 29, 2021 | From the USPTO record |